Laminar Pharmaceuticals S.A.

Spanish biopharmaceutical company founded in 2006 as a spin-off of the University of the Balearic Islands in Palma de Mallorca, discovering and developing drugs based on Membrane-Lipid Therapy, an approach that targets the lipid composition of cell membranes, with cancer and neurological candidates in clinical development and a subsidiary office in Massachusetts.